Titan Pharmaceuticals Inc (TTNP)
6.82
+0.08
(+1.19%)
USD |
NASDAQ |
May 08, 16:00
6.75
-0.07
(-1.03%)
After-Hours: 20:00
Titan Pharmaceuticals Enterprise Value: -0.0242M for May 8, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 08, 2024 | -0.0242M |
| May 07, 2024 | -0.0973M |
| May 06, 2024 | 0.0307M |
| May 03, 2024 | 0.0307M |
| May 02, 2024 | -0.1339M |
| May 01, 2024 | -0.1339M |
| April 30, 2024 | -0.1293M |
| April 29, 2024 | 0.0033M |
| April 26, 2024 | 0.2227M |
| April 25, 2024 | 0.113M |
| April 24, 2024 | 0.113M |
| April 23, 2024 | 0.1495M |
| April 22, 2024 | 0.1495M |
| April 19, 2024 | 0.4325M |
| April 18, 2024 | 0.2318M |
| April 17, 2024 | 0.2318M |
| April 16, 2024 | 0.3755M |
| April 15, 2024 | 0.3755M |
| April 12, 2024 | 0.3781M |
| April 11, 2024 | 0.2867M |
| April 10, 2024 | 0.4512M |
| April 09, 2024 | 0.4512M |
| April 08, 2024 | 0.3598M |
| April 05, 2024 | 0.0033M |
| April 04, 2024 | 0.0398M |
| Date | Value |
|---|---|
| April 03, 2024 | 0.0581M |
| April 02, 2024 | 0.305M |
| April 01, 2024 | 0.1038M |
| March 28, 2024 | 0.2867M |
| March 27, 2024 | 0.4878M |
| March 26, 2024 | 0.353M |
| March 25, 2024 | 0.0033M |
| March 22, 2024 | -1.180M |
| March 21, 2024 | -0.696M |
| March 20, 2024 | -0.7445M |
| March 19, 2024 | -0.3327M |
| March 18, 2024 | -0.3408M |
| March 15, 2024 | 0.7392M |
| March 14, 2024 | -0.4511M |
| March 13, 2024 | -0.6921M |
| March 12, 2024 | -0.2401M |
| March 11, 2024 | -0.5015M |
| March 08, 2024 | -0.8804M |
| March 07, 2024 | -0.8804M |
| March 06, 2024 | -0.8804M |
| March 05, 2024 | -0.8955M |
| March 04, 2024 | -0.4963M |
| March 01, 2024 | -0.6093M |
| February 29, 2024 | -0.6093M |
| February 28, 2024 | -0.4693M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-3.708M
Minimum
Dec 21 2023
41.28M
Maximum
Nov 20 2020
11.88M
Average
11.06M
Median
Feb 28 2023
Enterprise Value Benchmarks
| Outset Medical Inc | 135.38M |
| Allurion Technologies Inc | 102.20M |
| AIM ImmunoTech Inc | 8.832M |
| Protalix BioTherapeutics Inc | 58.97M |
| Armata Pharmaceuticals Inc | 168.55M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.97M |
| Total Expenses (Quarterly) | 1.931M |
| EPS Diluted (Quarterly) | -2.61 |
| Earnings Yield | -108.7% |
| Normalized Earnings Yield | -167.01 |